Lynk Solutec has received a Rare Medical Device designation from the Ministry of Food and Drug Safety (MFDS) for its LYNKS Frontalis Suspension Set, a suture indicated for ptosis correction surgery. Details are as follows.

1. Product: LYNKS Frontalis Suspension Set (Non-absorbable Suture)
2. Designating Authority: Ministry of Food and Drug Safety (MFDS), Republic of Korea
3. Designation Date: January 2025
4. Indication: Surgical correction of ptosis (drooping eyelid) in pediatric and adult patients
5. Designation Background
   • Product discontinuation following ownership change and business conversion of the sole global manufacturer
   • Designated as an urgently needed medical device due to absence of domestic supply alternatives

(END)

Lynk Solutec has been selected for the Korea Public Procurement Service (PPS) Innovation Product Pilot Procurement Program and has concluded a supply contract for its C.E.V. (Clear Endo Vision) endoscopic connector. Details are as follows.

1. Product: C.E.V. (Clear Endo Vision) Endoscopic Connector
2. Contracting Authority: Korea Public Procurement Service (PPS)
   • Receiving Institutions: Konyang University Hospital, Korea University Ansan Hospital
3. Contract Basis: Negotiated contract pursuant to Ministry of SMEs and Startups (MSME) Innovation Product designation (July 2025)
4. Contract Date: June 29, 2026
5. Contract Scope
   • PPS purchases and distributes the product to receiving institutions
   • Innovation performance evaluation to follow upon completion of pilot supply
   • Eligible for preferential treatment in Excellence Procurement Product designation review
   • Negotiated contract rights valid for three years from Innovation Product designation date

※ Purchasing institutions are protected under procurement indemnity provisions of the PPS Innovation Product Pilot Procurement Program.

(END)

Lynk Solutec has been selected as a recipient of the SBA Bio-Medical Technology Commercialization Support Program, operated by the Seoul Business Agency (SBA). Details are as follows.

1. Program: SBA Bio-Medical Technology Commercialization Support Program
2. Supervising Authority: Seoul Business Agency (SBA)
3. Project Title: Development of Innovative Medical Devices Applying Bio-Adhesion Prevention Coating (Lynk Coating)
4. Selection Date: July 1, 2026
5. Project Period: July 1, 2026 – June 30, 2028 (24 months)
6. Funding
   • Total Grant Amount: KRW 400,000,000
   • Principal Institution: Lynk Solutec Co., Ltd.
7. Project Scope
   • Development and commercialization of innovative medical devices incorporating the company’s proprietary bio-adhesion prevention coating technology (Lynk Coating)

(END)